Skip to main content

Client News

Newron announces 2019 financial results and provides outlook for 2020

5th March 2020

Imcyse SA: Imcyse Joins Type 1 Diabetes IMI Consortium INNODIA

4th March 2020

4basebio AG announces allotment ratio and final number of shares for the share buy back

4th March 2020

InfanDx receives BMBF grant to develop companion diagnostic test to identify newborns likely to benefit from neuroprotective hypothermia treatment

3rd March 2020

CENTOGENE AG: CENTOGENE Marks Rare Disease Day 2020 With a Global Line up of Events

29th February 2020

InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum

26th February 2020

APEIRON’s respiratory drug product to start pilot clinical trial to treat coronavirus disease COVID-19 in China

26th February 2020

Imcyse SA: Imcyse to present late-breaking abstract of its Imotope™-based antigen-specific immunotherapy for autoimmune diseases at ASIT 2020

24th February 2020

4basebio AG announces allotment ratio and final number of shares for the share buy back

21st February 2020

Adrenomed Announces Positive Top-Line AdrenOSS-2 Phase II Results with Adrecizumab in Septic Shock

21st February 2020